Healthcare

ASX biotech companies creating a pandemic-free buzz!
June 21, 2020 12:00 AM AEST| By Team Kalkine MediaAs on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide. And with no sign to the ending of this human loss, an indispensable need for a vaccine or a treatment has .....

Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and API
June 16, 2020 06:57 PM AEST| By Team Kalkine MediaThe healthcare sector is a significant and complex sector comprising a variety of companies engaged in manufacturing, developing, and selling of medical devices, drugs, and services. The healthcare system in Australia is one of the most robust ones.....

Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovation, Boost R&D Efforts
June 12, 2020 02:49 PM AEST| By Team Kalkine MediaIn the healthcare world, the general trend has been that smaller biotech players work on the innovation angle with research and development activities, while the more prominent players handle the marketing and commercialisation activities as they h.....

3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1
June 11, 2020 02:53 PM AEST| By Team Kalkine MediaSmall-cap stocks are listed companies with market capitalisation varying from USD 300 million to USD 2 billion or less. And in these stocks, there are plenty of promising investment opportunities. Despite their smaller size, small-cap stocks have s.....

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASCO 2020 Annual Meeting
June 03, 2020 11:42 AM AEST| By Team Kalkine MediaSummary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at ASCO 2020 Annual Meeting. Highly encouraging interim data from the Phase 1b/2a LuPIN clinical trial.....

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2 Million
April 17, 2020 01:14 PM AEST| By Team Kalkine MediaAustralian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcomes for the March quarter 2020. The Company is engaged in the development of new drugs that demonstr...

Lens over SUDA’s Operational Highlights in 1H FY20
March 04, 2020 01:59 PM AEDT| By Hina ChowdharyContinuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declared results for the half-year period ended 31st December 2019. The Company continued to focus on attr...

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx
January 15, 2020 04:50 PM AEDT| By Hina ChowdharyIt’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in the largest pharmaceutical market of the world. The United States Patent and Trademark Office (USPTO...

Prescient Collaborates with Carina Biotech in Expansion into Exciting CAR-T Therapies
December 10, 2019 04:19 PM AEDT| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX) develops personalised medicine approaches to address mutations that cause cancer. The Company employs a targeted therapy approach to target individual tumour variability rather than the conventional one size...

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics
November 25, 2019 06:06 PM AEDT| By Team Kalkine MediaHealth care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology. Health care sector comprises of providers of medical services, medical insurance, and medical equip...

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market
August 20, 2019 04:36 PM AEST| By Team Kalkine MediaImugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to enable a patient?s immune system to recognise and destroy cancer cells. The company is focused on targe...

Journey of Prescient Therapeutics in 2019
July 25, 2019 12:38 PM AEST| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio of the company includes two drug candidates, PTX 100 and PTX 200, under the development phase. Both...

Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ Drug
July 24, 2019 04:54 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxopharm reports on the progress of its lead anti-cancer drug candidate Veyonda? achieved over the past...

An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials
July 22, 2019 07:22 PM AEST| By Team Kalkine MediaAn Australian-based biotechnology company, Imugene Limited (ASX: IMU) focuses on the development of cancer immunotherapies targeted at activating the immune system of cancer patients. The company?s exceptional platform technology helps in stimulating...

A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy
June 28, 2019 04:36 PM AEST| By Team Kalkine MediaAn Australian-headquartered clinical stage immuno-oncology company, Imugene Limited (ASX: IMU) has a robust pipeline of B cell vaccines aimed at treating a variety of cancers. The company?s pipeline includes multiple product candidates that are used...

AFP’s FY19 Performance - What investors need to know?
May 23, 2019 01:50 PM AEST| By Team Kalkine MediaAFT Pharmaceuticals Limited (ASX: AFP) is a growing pharma company with its head office based out of New Zealand. It officially was listed on ASX in December 2015. On 22nd May 2019, the company published its Investor Presentation and Annual Report, c...

Kazia Therapeutics collaborates with Alliance to investigate new drug, GDC-0084
May 21, 2019 01:42 PM AEST| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) caters to the health care sector and is based out of Sydney, Australia. It is a bio-tech company which focusses on innovative oncology. The company aims to bring out diversified portfolio of new cancer therapies....

GMV executes two Provider Participation Agreements with United States-based companies
May 16, 2019 04:09 PM AEST| By Team Kalkine MediaG Medical Innovations Holdings Limited (ASX: GMV) is a healthcare company focused on digital health solutions. On 16 May 2019, GMV reported that its wholly owned subsidiary G Medical Diagnostic Services Inc (GMEDx) had executed two Provider Particip...

Looking Through The Business Model Of This Drug Development Company – Noxopharm
May 10, 2019 12:06 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) rides on its overarching objective for a treatment ?to harness the body?s immune system to attack all the cancer cells in the body, but with noticeably reduced side-effects. The company is positioned as a clinical-stage d...

Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited
May 03, 2019 04:17 PM AEST| By Team Kalkine MediaToday, on 3rd May 2019, Respiri Limited (ASX: RSH) announces a Joint Venture Agreement for the company?s entry into India with MedAchievers Private Limited, which is an integrated platform for global healthcare, led by Dr Harsha Vardhan, Founder and...

Advertise your brand on Kalkine Media